Tag: #Global Trends

Biopharmaceutical developer Travere Therapeutics has entered into a definitive global licensing covenant with biotechnology firm Everest Medicines to collaboratively develop... Read more

WASHINGTON/LONDON (Reuters) — U.S. Secretary of State Marco Rubio has formally announced that the United States will resume its operational... Read more

The United States Food and Drug Administration (FDA) has formally accepted Roche's New Drug Application (NDA) and granted Priority Review... Read more

U.S. pharmaceutical titan Merck & Co. has initiated the next phase of its ongoing corporate reorganization, cutting 88 positions at... Read more

International financial and medical registries have logged a major wave of capital reallocation as dominant U.S. and European pharmaceutical conglomerates... Read more

German biotechnology developer T-CURX has entered into a definitive agreement to acquire its domestic peer, Pantherna Therapeutics, to systematically advance... Read more

Global contract development and manufacturing organization (CDMO) Intravacc and biotechnology developer Primrose Bio have formalized a definitive renewal of their... Read more

TOKYO (Reuters) — Japan's Shionogi & Co has announced that the U.S. Food and Drug Administration (FDA) has officially approved... Read more

The Coalition for Epidemic Preparedness Innovations (CEPI) has formalized a financial commitment of approximately $60 million distributed across Moderna and... Read more